Cargando…
Combining thioridazine and loratadine for the treatment of gastrointestinal tumor
In 2015, the American Society of Clinical Oncology announced that strategies of using combination therapies have been indicated to be effective against many types of cancer. In the present study, thioridazine (THZ) was used in a combination therapy with loratadine (LOR) to target gastrointestinal tu...
Autores principales: | Chen, Tingting, Hu, Yunlong, Liu, Bin, Huang, Xinping, Li, Qin, Gao, Ningning, Jin, Zhenchao, Jia, Tieliu, Guo, Deyin, Jin, Guangyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649607/ https://www.ncbi.nlm.nih.gov/pubmed/29085455 http://dx.doi.org/10.3892/ol.2017.6815 |
Ejemplares similares
-
Ethacrynic acid improves the antitumor effects of irreversible epidermal growth factor receptor tyrosine kinase inhibitors in breast cancer
por: Liu, Bing, et al.
Publicado: (2016) -
Effect of Thioridazine on Erythrocytes
por: Lang, Elisabeth, et al.
Publicado: (2013) -
Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy
por: Jin, Xun, et al.
Publicado: (2016) -
The Effect of Fluphenazine and Thioridazine on Toxoplasma gondii In Vivo
por: SARAEI, Mehrzad, et al.
Publicado: (2016) -
Molecular mechanisms of thioridazine resistance in Staphylococcus aureus
por: Wassmann, Claes Søndergaard, et al.
Publicado: (2018)